Cargando…
Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats
BACKGROUND: Rat adipose tissue-derived-mesenchymal stem cells (rAD-MSCs) have proven to be safe in experimental animal models of stroke. However, in order to use human AD-MSCs (hAD-MSCs) as a treatment for stroke patients, a proof of concept is needed. We analyzed whether the xenogeneic hAD-MSCs wer...
Autores principales: | Gutiérrez-Fernández, María, Rodríguez-Frutos, Berta, Ramos-Cejudo, Jaime, Otero-Ortega, Laura, Fuentes, Blanca, Vallejo-Cremades, María Teresa, Sanz-Cuesta, Borja Enrique, Díez-Tejedor, Exuperio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322805/ https://www.ncbi.nlm.nih.gov/pubmed/25637958 http://dx.doi.org/10.1186/s12967-015-0406-3 |
Ejemplares similares
-
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke
por: Gutiérrez-Fernández, María, et al.
Publicado: (2013) -
Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke
por: Gutiérrez-Fernández, María, et al.
Publicado: (2012) -
White matter injury restoration after stem cell administration in subcortical ischemic stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2015) -
White Matter Repair After Extracellular Vesicles Administration in an Experimental Animal Model of Subcortical Stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2017) -
Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial
por: de Celis-Ruiz, Elena, et al.
Publicado: (2022)